Puma Biotechnology | Fremdkapital

Aktienkurs
6.82
Täglich Wechseln
0.02 0.29%
Monatlich
6.23%
Jährlich
138.46%
Q1 Prognose
6.61




Fremdkapital Veränderung Datum
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Esperion Therapeutics USD 262.48M 235.95M 2024-06
Gilead Sciences USD 22.14B 5M 2025-09
Glaxosmithkline GBP 20.02B 4.72B 2025-09
Incyte USD 35.37M 3.61M 2025-09
MacroGenics USD 70.26M 4K 2025-09
Moderna USD 610M 584M 2025-12
Novartis USD 24.24B 174M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Takeda JPY 4.27T 81.29B 2025-12
TG Therapeutics USD 245.34M 303K 2025-09
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03


Puma Biotechnology Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.